Infection Control for Severe Acute Respiratory Syndrome Coronavirus 2

NCT04665960 | Completed

• 1 other identifier: NMCSpecialtyH
• Study Type: observational
• Target: 35
• Locations: 1 country
• Sites: 1

Brief Summary

The investigators aim to develop expert consensus statements on infection control management of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in intensive care units (ICU).

Conditions

Covid19; SARS-CoV Infection; SARS Pneumonia; Coronavirus Infection; Infection

Keywords

Infection Control; Intensive care unit; SARS-CoV-2; COVID-19

Outcome Measures

Primary Outcomes (1)

• Consensus using participating experts opinions.

  For statements with responses on an ordinal 7-point Likert scale, 'agreement' is defined as a score of 5-7, 'neutral' by a score of 4 and 'disagreement' by a score of 1-3. Consensus is defined as achieved when \>70% of the experts voted for a given option in Likert scale statement. Median and interquartile range (IQR) were used to describe the central tendency and dispersion of responses. For multiple-choice questions (MCQs), consensus is defined as achieved if \>80% of the experts voted for a particular option. Stability in the responses will be assessed from round two onwards. Stability will be assessed between the two concluding rounds for each statement, using the non-parametric chi square (χ2) test. p \< 0·05 is considered as a significant variation or unstable.

  30 days

Eligibility Criteria

• Age: 25 Years - 70 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

40 global experts in infectious disease, infection control, sepsis, respiratory failure or public health and involved in the management of COVD-19 will be invited to participate in study through e-mail with final expected participation of 35-40 experts.

Sponsors & Collaborators

• NMC Specialty Hospital: lead

Study Sites (1)

NMC Specialty Hospital

Dubai, 7832, United Arab Emirates

Location

Related Publications (2)

• Odor PM, Neun M, Bampoe S, Clark S, Heaton D, Hoogenboom EM, Patel A, Brown M, Kamming D. Anaesthesia and COVID-19: infection control. Br J Anaesth. 2020 Jul;125(1):16-24. doi: 10.1016/j.bja.2020.03.025. Epub 2020 Apr 8.

  PMID: 32307115 BACKGROUND

• Wax RS, Christian MD. Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients. Can J Anaesth. 2020 May;67(5):568-576. doi: 10.1007/s12630-020-01591-x. Epub 2020 Feb 12.

  PMID: 32052373 BACKGROUND

Related Links

• World Health Organisation (WHO). Infection prevention and control guidance - (COVID-19). Updated September 11, 2020.

MeSH Terms

Conditions

COVID-19; Severe Acute Respiratory Syndrome; Coronavirus Infections; Infections

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Virus Diseases; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Sheila Myatra, MD

  Tata Memorial Hospital, Mumbai, India

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Head Critical Care Medicine

Study Record Dates

• First Submitted: December 9, 2020
• First Posted: December 14, 2020
• Study Start: March 29, 2021
• Primary Completion: April 25, 2021
• Study Completion: May 1, 2021
• Last Updated: May 11, 2021

Record last verified: 2021-05

Locations

AE (1)